Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure

被引:0
|
作者
Beldhuis, I. E. [1 ]
Damman, K. [1 ]
Davison, B. A. [2 ]
Filippatos, G. S. [3 ]
Greenberg, B. H. [4 ]
Felker, G. M. [5 ]
Pang, P. S. [6 ]
Gimpelewicz, C. [7 ]
Teerlink, J. R. [8 ]
Metra, M. [9 ]
Voors, A. A. [1 ]
机构
[1] Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[2] Inserm, UMR S 942, Paris, France
[3] Natl & Kapodistrian Univ Athens, Med Sch, Dept Cardiol, Athens, Greece
[4] UC San Diego Hlth, Sulpizio Family Cardiovasc Ctr, La Jolla, CA USA
[5] Duke Univ, Sch Med, Durham, NC USA
[6] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN USA
[7] Novartis Pharmaceut, Basel, Switzerland
[8] San Francisco VA Med Ctr, Cardiol Sect, San Francisco, CA USA
[9] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Brescia, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:174 / 174
页数:1
相关论文
共 50 条
  • [21] Improved Diastolic Function Is Associated With Higher Cardiac Output in Patients With Heart Failure Irrespective of Left Ventricular Ejection Fraction
    Tobushi, Tomoyuki
    Nakano, Masatsugu
    Hosokawa, Kazuya
    Koga, Hidenobu
    Yamada, Akira
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (03):
  • [22] Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients With Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial)
    Vaduganathan, Muthiah
    Dei Cas, Alessandra
    Mentz, Robert J.
    Greene, Stephen J.
    Khan, Sadiya
    Subacius, Haris P.
    Chioncel, Ovidiu
    Maggioni, Aldo P.
    Konstam, Marvin A.
    Senni, Michele
    Fonarow, Gregg C.
    Butler, Javed
    Gheorghiade, Mihai
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (05): : 743 - 750
  • [23] Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomes
    Jarjour, Marilyne
    Leclerc, Jacinthe
    Bouabdallaoui, Nadia
    Ahnadi, Charaf
    Brouillette, Denis
    de Denus, Simon
    Fortier, Annik
    Garceau, Patrick
    Giraldeau, Genevieve
    Lepage, Serge
    Liszkowski, Mark
    O'Meara, Eileen
    Parent, Marie -Claude
    Racine, Normand
    Tremblay-Gravel, Maxime
    White, Michel
    Rouleau, Jean-Lucien
    Ducharme, Anique
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 370 : 300 - 308
  • [24] Lower Heart Rate Associated With Improved Outcomes in Heart Failure With Preserved Ejection Fraction
    Cunningham, Luke
    Deswal, Anita
    Chan, Wenyaw
    Augilar, David
    Bozkurt, Biykem
    Ramasubbu, Kumudha
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (08) : S87 - S87
  • [25] Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction
    Gao, Chen
    Xiong, Zhaojun
    Liu, Yunxia
    Wang, Meng
    Wang, Menglong
    Liu, Tian
    Liu, Jianfang
    Ren, Shuxun
    Cao, Nancy
    Yan, Hai
    Drucker, Daniel J.
    Rau, Christoph Daniel
    Yokota, Tomohiro
    Huang, Jijun
    Wang, Yibin
    CIRCULATION RESEARCH, 2024, 135 (05) : 614 - 628
  • [26] Interaction Between Mineralocorticoid Receptor Antagonist and Soluble ST2 in Heart Failure With Preserved Ejection Fraction
    Sugano, Akinori
    Seo, Yoshihiro
    Ishizu, Tomoko
    Yamamoto, Masayoshi
    Aonuma, Kazutaka
    Iesaka, Yoshito
    Nogami, Akihiko
    CIRCULATION, 2017, 136
  • [27] Outcomes Of Heart Failure With Improved Stable Ejection Fraction Vs. Heart Failure With Relapsed Ejection Fraction
    Liu, Vanessa
    Alwash, Hashim
    Khalife, Wissam
    Sanchez, Carlos
    Erana, Javier
    Wang, Charles
    Soufi, Mohamad Khaled
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 219 - 219
  • [28] The use of mineralocorticoid receptor antagonists for patients with heart failure with a reduced ejection fraction: A time for reassessment
    Pitt, Bertram
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (12) : 2174 - 2176
  • [29] Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection Fraction
    Matsumoto, Shingo
    Kondo, Toru
    Jhund, Pardeep S.
    Campbell, Ross T.
    Swedberg, Karl
    van Veldhuisen, Dirk J.
    Pocock, Stuart J.
    Pitt, Bertram
    Zannad, Faiez
    McMurray, John J. V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (11) : 1080 - 1091
  • [30] Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure
    Cooper, Lauren B.
    Hammill, Bradley G.
    Peterson, Eric D.
    Pitt, Bertram
    Maciejewski, Matthew L.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2017, 10 (01):